Nuvation Bio NUVB Operating Income
Discontinued — last reported Q1 '26
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvation Bio's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Nuvation Bio's operating income?
- Nuvation Bio (NUVB) reported operating income of $3.88M in Q1 2026.
- How has Nuvation Bio's operating income changed year-over-year?
- Nuvation Bio's operating income increased by 106.6% year-over-year, from -$59M to $3.88M.
- What is the long-term trend for Nuvation Bio's operating income?
- Over 4 years (2021 to 2025), Nuvation Bio's operating income has grown at a 22.9% compound annual growth rate (CAGR), from -$93.32M to -$213.06M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.